The authors report the long-term prospective follow-up of two unrelated fem
ales with congenital hypomyelinating neuropathy (CHN) and review previously
reported cases. The authors' first patient presented with neonatal hypoton
ia and extremely slow nerve conduction velocities. Sural nerve biopsy revea
led profound hypomyelination, without inflammation or evidence of myelin br
eakdown, She is now 9 years of age, and her motor function has continued to
improve, Follow-up nerve-conduction velocities are unchanged. The authors'
second patient presented at 5 months with hypotonia, Nerve-conduction velo
cities were extremely slow, and sural nerve biopsy revealed severe hypomyel
ination, with no inflammation or evidence of myelin breakdown. She is now 5
years of age and has also demonstrated improved motor function, Repeated n
erve-conduction velocities are unchanged, Both patients have normal cogniti
ve development. Molecular genetic analysis in Patient 2 disclosed a point m
utation in the myelin protein zero gene; this same point mutation has been
reported in three other patients diagnosed with Dejerine-Sottas syndrome (D
SS) but has never been reported in a patient with CHN. Although CHN is a di
stinct clinical entity, it may share similar genetic features with DSS, (C)
1999 by Elsevier Science Inc. All rights reserved.